the ability of cancer cells to effectively evade recognition by immune effectors, impaired tumor-associated antigen presentation and the absence of danger-associated molecular patterns (DAMPs) and loss of sensitivity to interferon gamma (IFNγ).17 The gene discussed is IFNG; the disease is cancer.